CLINICAL_TRIALS
research
· 2016-05-02
Clinical Trial Update: Symptomatic Treatment of Vascular Cognitive Impairment [Phase 2, Phase 3]
Summary
A clinical trial update describing a Phase 2/Phase 3 study of symptomatic treatment for vascular cognitive impairment, with current status unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Amsterdam UMC, location VUmc | Conditions: Mild Cognitive Impairment (Vascular), Mild Cognitive Disorder (Vascular) | Phase 2, Phase 3 | Status: UNKNOWN